Login / Signup

Genetic variation in IL28B (IFNL3) and response to interferon-alpha treatment in myeloproliferative neoplasms.

Marie LindgrenJan SamuelssonLars NilssonHåvar KnutsenWaleed GhanimaJohan WestinPeter L JohanssonBjörn Andréasson
Published in: European journal of haematology (2018)
These results imply an effect of IL28B genotype on the outcome of IFN-α treatment in MPN.
Keyphrases
  • dendritic cells
  • combination therapy
  • replacement therapy